What are the incubation periods for common sexually transmitted infections such as chlamydia, gonorrhea, syphilis, herpes simplex virus, human papillomavirus, HIV, hepatitis B, hepatitis C, and Trichomonas vaginalis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incubation Periods for Common Sexually Transmitted Infections

The incubation periods for common STIs vary widely, from as short as 1–3 days for gonorrhea to as long as 10–90 days for HIV and hepatitis B, with many infections remaining asymptomatic throughout, making knowledge of these windows critical for post-exposure testing and partner notification.

Bacterial STIs

Gonorrhea (Neisseria gonorrhoeae)

  • Incubation period: 1–14 days (most commonly 2–5 days after exposure) 1
  • Urethral symptoms in men typically appear within 2–5 days, though 53–100% of extragenital infections (rectal, pharyngeal) remain asymptomatic 1
  • The 60-day partner notification window recommended by CDC reflects both the incubation period and the period during which asymptomatic transmission occurs 2

Chlamydia (Chlamydia trachomatis)

  • Incubation period: 7–21 days (average 14 days) 3
  • Among adolescent women, 25% acquire chlamydia within 1 year of first intercourse, with a median interval of 2 years between first intercourse and first diagnosis 4
  • The 60-day exposure period for partner notification accounts for the prolonged asymptomatic phase during which transmission occurs 2
  • Up to 70% of infections remain asymptomatic, contributing to delayed diagnosis and ongoing transmission 1, 5

Syphilis (Treponema pallidum)

  • Incubation period: 10–90 days (average 21 days) for primary chancre to appear 3
  • The chancre typically develops 3 weeks after exposure and heals spontaneously within 3–6 weeks even without treatment 2
  • Secondary syphilis manifestations appear 4–10 weeks after the chancre (approximately 6 weeks to 6 months after initial infection) 2
  • Serologic testing requires both treponemal and nontreponemal assays because antibodies may not be detectable during early incubation 6, 1

Parasitic STIs

Trichomoniasis (Trichomonas vaginalis)

  • Incubation period: 4–28 days (average 7 days) 3
  • Approximately 70% of infections are asymptomatic, particularly in men 1
  • The U.S. sees an estimated 5 million cases annually, making it one of the most common curable STIs 5
  • Reinfection occurs rapidly; 25% of women with prior infection are reinfected within 4.8 months 4

Viral STIs

Herpes Simplex Virus (HSV-1 and HSV-2)

  • Incubation period: 2–12 days (average 4 days) for primary outbreak 3
  • Initial lesions appear 2–12 days after exposure, with viral shedding beginning before lesions are visible 2
  • Many primary infections are asymptomatic or unrecognized, and HSV can remain latent for years before first clinical outbreak 1
  • Serologic testing is not recommended for asymptomatic individuals because it does not change management and false-positives are common 6

Human Papillomavirus (HPV)

  • Incubation period: 3 weeks to 8 months (average 2–3 months) for visible genital warts 2
  • High-risk HPV types (causing cervical dysplasia) rarely produce visible warts and can remain undetected for years 2
  • HPV infection can be present for many years before detection, and no method can accurately confirm when infection was acquired 2
  • There is no blood test for HPV; diagnosis relies on visualization of lesions or cervical/anal cytology 6

Human Immunodeficiency Virus (HIV)

  • Incubation period for acute retroviral syndrome: 10–28 days (average 2–4 weeks) after exposure 2
  • Fourth-generation HIV tests (antibody + p24 antigen) can detect infection 2–4 weeks post-exposure, earlier than antibody-only tests which require 3–6 weeks 6
  • Greater than 95% of patients develop detectable antibodies within 6 months of infection 2
  • The 12-week (3-month) follow-up testing window after sexual assault accounts for the serologic window period 2

Hepatitis B Virus (HBV)

  • Incubation period: 6 weeks to 6 months (average 90 days from exposure to symptom onset) 7, 2
  • HBsAg becomes detectable on average 30 days post-exposure (range 6–60 days), while HBV DNA can be identified 10–20 days earlier 7
  • Abnormal liver enzymes appear on average 60 days after exposure (range 40–90 days) 7
  • Jaundice develops on average 90 days after exposure (range 60–150 days) 7
  • Infants and children under 5 years are typically asymptomatic (only 10% develop symptoms) but have an 80–90% risk of chronic infection 7
  • Older children and adults develop symptomatic acute hepatitis in 30–50% of infections 7

Hepatitis A Virus (HAV)

  • Incubation period: 15–50 days (average 28 days) 2
  • HAV replicates in the liver and is shed in high concentrations in feces from 2 weeks before to 1 week after symptom onset 2
  • Transmission occurs primarily through fecal-oral contact during sexual activity, particularly among men who have sex with men 2

Hepatitis C Virus (HCV)

  • Incubation period: 2 weeks to 6 months (average 6–7 weeks) for acute infection 8
  • Sexual transmission is increasingly recognized, particularly among HIV-positive men who have sex with men 6
  • Antibody testing with reflex to RNA PCR is required because antibodies may not appear during early infection 6

Clinical Implications for Testing Windows

Immediate Post-Exposure Testing (Baseline)

  • Collect baseline specimens for gonorrhea, chlamydia, and trichomoniasis using NAATs from all sites of exposure 2, 6
  • Obtain baseline serology for syphilis, HIV, and hepatitis B to document pre-exposure status 2
  • Testing during the incubation period will often yield false-negative results because infectious agents have not produced sufficient organism concentrations 2

2-Week Follow-Up

  • Repeat cultures and NAATs for gonorrhea, chlamydia, and trichomoniasis because initial testing may have occurred during the incubation period 2
  • This timing captures infections with shorter incubation periods (gonorrhea, chlamydia, trichomoniasis, HSV) 2

12-Week (3-Month) Follow-Up

  • Repeat serologic testing for syphilis, HIV, and hepatitis B to allow time for antibody development 2
  • This window accounts for the longest incubation periods and serologic window periods 2, 7
  • If positive, testing of baseline sera assists in determining whether infection preceded the exposure 2

Common Pitfalls

  • Do not assume negative initial testing rules out infection—many STIs are in the incubation period during the first 1–2 weeks after exposure, requiring repeat testing at 2 weeks and 3 months 2
  • Do not rely on symptoms to guide testing—53–100% of extragenital gonorrhea/chlamydia and 70% of HSV/trichomoniasis infections are asymptomatic 1
  • Do not delay partner notification until test results return—the 60-day partner notification window for bacterial STIs reflects both incubation periods and asymptomatic transmission phases 2
  • Do not order HSV serology for asymptomatic patients—it does not change management and false-positives are common in low-prevalence populations 6
  • Do not assume a single negative HIV test at 4–6 weeks is definitive—repeat testing at 12 weeks is required to cover the full serologic window period 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sexually transmitted diseases.

Primary care, 2013

Guideline

STD Testing and Treatment Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hepatitis B Incubation Period and Clinical Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Sexually transmitted viral hepatitis and enteric pathogens.

The Urologic clinics of North America, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.